Nvidia's $50M Leap into AI-Driven Drug Discovery

In this episode, we delve into Nvidia's significant investment of $50 million in Recursion, an AI drug discovery firm. We explore the potential impact of this collaboration on the future of pharmaceutical research and healthcare innovation.

• Invest in AI Box: https://Republic.com/ai-box

• Get on the AI Box Waitlist: ⁠⁠https://AIBox.ai/⁠⁠

• AI Facebook Community

• Learn more about AI in Video

• Learn more about Open AI